Key statistics dashboard for BNB Plus Corp. (BNBX). Valuation multiples (P/E, P/B, EV/EBITDA), profitability margins, financial-health ratios, per-share metrics and stock-level data in one consolidated view — the snapshot quantitative analysts and value investors check first.
BNB Plus Corp., established in 1983 and based in Stony Brook, NY, is a biotechnology firm dedicated to pioneering and commercializing technologies for the synthesis and identification of both deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company's operations are divided into three distinct business segments.
Stock Data
| Price | $0.16 |
| Market Cap | $0M |
| Exchange | NASDAQ |
| Country | US |
Valuation Multiples
| P/E Ratio | -0.00 |
| Price / Book | 0.13 |
| P/S | 0.10 |
| P/FCF | -0.02 |
| Dividend Yield | 0.00% |
Profitability
| Gross Margin | 43.49% |
| EBIT Margin | -1670.74% |
| EBITDA Margin | -1657.56% |
| Operating Margin | -1209.55% |
| Net Margin | -1646.94% |
Financial Health
| Current Ratio | 1.82 |
| Quick Ratio | 1.74 |
| Cash Ratio | 0.64 |
| Debt / Equity | 0.00 |
| Debt / Assets | 0.00% |
| Interest Coverage | 0.00 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -130.65 |
Per-Share Data
| Revenue per share | 0.22 |
| Book Value per share | 1.25 |
| Cash per share | 0.10 |
| FCF per share | -1.42 |
| Tangible Book Value per share | 1.11 |
| Dividend per share | 0.00 |
Related companies: BGMS · BNGO · CANF · ISPC · KZIA · NAOV · NDRA
Explore sector: Healthcare · Biotechnology
More sections of BNBX: Overview · Financials · Valuation · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks